Cargando…

Apolipoprotein CIII Overexpression-Induced Hypertriglyceridemia Increases Nonalcoholic Fatty Liver Disease in Association with Inflammation and Cell Death

Nonalcoholic fatty liver disease (NAFLD) is the principal manifestation of liver disease in obesity and metabolic syndrome. By comparing hypertriglyceridemic transgenic mice expressing apolipoprotein (apo) CIII with control nontransgenic (NTg) littermates, we demonstrated that overexpression of apoC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paiva, Adriene A., Raposo, Helena F., Wanschel, Amarylis C. B. A., Nardelli, Tarlliza R., Oliveira, Helena C. F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259655/ https://www.ncbi.nlm.nih.gov/pubmed/28163820 http://dx.doi.org/10.1155/2017/1838679

Ejemplares similares

Apolipoprotein CIII overexpression exacerbates diet-induced obesity due to adipose tissue higher exogenous lipid uptake and retention and lower lipolysis rates
por: Raposo, Helena F., et al.
Publicado: (2015)

Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia
por: Guan, Yunpeng, et al.
Publicado: (2021)

Apolipoprotein CIII Overexpressing Mice Are Predisposed to Diet-Induced Hepatic Steatosis and Hepatic Insulin Resistance
por: Lee, Hui-Young, et al.
Publicado: (2011)

Meal-Related Changes in Apolipoprotein Particles After Treatment With an Antisense Oligonucleotide to Apolipoprotein CIII
por: Brite, Brianna, et al.
Publicado: (2021)

Associations between apolipoprotein CIII concentrations and microalbuminuria in type 2 diabetes
por: HU, ZHI-JUAN, et al.
Publicado: (2014)

Effects of dietary saturated fat on LDL subclasses and apolipoprotein CIII in men
por: Faghihnia, Nastaran, et al.
Publicado: (2012)

Apolipoprotein CIII Is an Important Piece in the Type-1 Diabetes Jigsaw Puzzle
por: Valladolid-Acebes, Ismael, et al.
Publicado: (2021)

CD14(+)-Monocytes Exposed to Apolipoprotein CIII Express Tissue Factor
por: Olivieri, Oliviero, et al.
Publicado: (2023)

Large-Scale Analysis of Apolipoprotein CIII Glycosylation by Ultrahigh Resolution Mass Spectrometry
por: Demus, Daniel, et al.
Publicado: (2021)

APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome
por: Fallaize, Rosalind, et al.
Publicado: (2017)

The Presence of Cholesteryl Ester Transfer Protein (CETP) in Endothelial Cells Generates Vascular Oxidative Stress and Endothelial Dysfunction
por: Wanschel, Amarylis C. B. A., et al.
Publicado: (2021)

Role of MAPK in apolipoprotein CIII-induced apoptosis in INS-1E cells
por: Sol, E-ri M, et al.
Publicado: (2009)

Statins suppress apolipoprotein CIII-induced vascular endothelial cell activation and monocyte adhesion
por: Zheng, Chunyu, et al.
Publicado: (2013)

Apolipoprotein CIII may mediate the impacts of angiopoietin-like protein 8 on triglyceride metabolism
por: Luo, Mengdie, et al.
Publicado: (2018)

Lowering apolipoprotein CIII protects against high-fat diet–induced metabolic derangements
por: Valladolid-Acebes, Ismael, et al.
Publicado: (2021)

Apolipoprotein-CIII O-Glycosylation, a Link between GALNT2 and Plasma Lipids
por: Naber, Annemieke, et al.
Publicado: (2023)

The relationship between apolipoprotein CIII gene polymorphism and serum lipid levels in Han Chinese males()
por: Su, Shu, et al.
Publicado: (2013)

Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?
por: Taskinen, Marja-Riitta, et al.
Publicado: (2016)

Mass Spectrometry of Transferrin and Apolipoprotein CIII from Dried Blood Spots for Congenital Disorders of Glycosylation
por: Wada, Yoshinao, et al.
Publicado: (2022)

Apolipoprotein CIII Reduction Protects White Adipose Tissues against Obesity-Induced Inflammation and Insulin Resistance in Mice
por: Recio-López, Patricia, et al.
Publicado: (2021)

Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia
por: Zhang, Shujun, et al.
Publicado: (2017)

SstI Polymorphism of the Apolipoprotein CIII Gene in Iranian Hyperlipidemic Patients: A Study in Semnan Province
por: Bandegi, Ahmad Reza, et al.
Publicado: (2011)

Association of serum lipids and coronary artery disease with polymorphisms in the apolipoprotein AI-CIII-AIV gene cluster
por: Rai, Himanshu, et al.
Publicado: (2016)

Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study
por: Katzmann, Julius L., et al.
Publicado: (2020)

Volanesorsen, an Antisense Oligonucleotide to Apolipoprotein-CIII, Decreases Triglycerides and Increases Lipoprotein Lipase Activity in Partial Lipodystrophy
por: Lightbourne, Marissa, et al.
Publicado: (2021)

Plasma Apolipoprotein CI and CIII Levels Are Associated With Increased Plasma Triglyceride Levels and Decreased Fat Mass in Men With the Metabolic Syndrome
por: van der Ham, Rachel L.M., et al.
Publicado: (2009)

Insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia
por: Whyte, Martin, et al.
Publicado: (2015)

Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia: Erratum
Publicado: (2017)

A Novel Role for RARα Agonists as Apolipoprotein CIII Inhibitors Identified from High Throughput Screening
por: Lee, Sang Jun, et al.
Publicado: (2017)

Editorial: Covid-19 Mechanisms on Cardio-Vascular Dysfunction: From Membrane Receptors to Immune Response
por: Wanschel, Amarylis C. B. A., et al.
Publicado: (2021)

Apolipoprotein CIII regulates lipoprotein-associated phospholipase A(2) expression via the MAPK and NFκB pathways
por: Han, Xiaolei, et al.
Publicado: (2015)

Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele
por: Olivieri, Oliviero, et al.
Publicado: (2013)

Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII
por: Olivieri, Oliviero, et al.
Publicado: (2019)

Electrospray Ionization Mass Spectrometry of Apolipoprotein CIII to Evaluate O-glycan Site Occupancy and Sialylation in Congenital Disorders of Glycosylation
por: Wada, Yoshinao, et al.
Publicado: (2022)

Editorial: COVID-19 mechanisms on cardio-vascular dysfunction: from membrane receptors to immune response, volume II
por: Moretti, Ana Iochabel Soares, et al.
Publicado: (2023)

Liver proteomic response to hypertriglyceridemia in human-apolipoprotein C-III transgenic mice at cellular and mitochondrial compartment levels
por: Ehx, Grégory, et al.
Publicado: (2014)

The Anti-atherogenic Role of Exercise Is Associated With the Attenuation of Bone Marrow-Derived Macrophage Activation and Migration in Hypercholesterolemic Mice
por: Rentz, Thiago, et al.
Publicado: (2020)

Role of Apolipoprotein A1 in PPAR Signaling Pathway for Nonalcoholic Fatty Liver Disease
por: Chen, Changxi, et al.
Publicado: (2022)

Lipoprotein Lipase/Apolipoprotein Cll Gene Polymorphism in Kurdish Patients With Severe Hypertriglyceridemia
por: Hussein, Kajeen, et al.
Publicado: (2023)

Is apoCIII-Lowering A Double-Edged Sword?
por: Tang, Xiangming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j4dug3tc85ercnsuod3iga3nd8